Nectar Lifesciences Limited has submitted a regulatory filing to the National Stock Exchange of India Limited (Symbol: NECLIFE) and BSE Limited (Scrip Code: 532649) pursuant to Regulation 30 of the SEBI LODR Regulations.

The disclosure intimates that pursuant to Regulation 36(1)(b) of the LODR Regulations, the company has sent a letter providing a web-link of the Annual Report 2025-26 to those members who have not registered their email addresses with the Company/Registrar & Transfer Agent/Depositories/Depository Participants. A copy of this letter was enclosed with the filing.

The enclosed letter to shareholders, dated August 22, 2026, provides detailed information about the 31st Annual General Meeting (AGM). The AGM is scheduled to be held on Friday, September 18, 2026 at 11:00 A.M. IST through video conference/other audio visual means to transact business as set out in the AGM Notice dated August 14, 2026.

Key AGM and E-voting Details:

  • Commencement of remote e-voting: From 9:00 A.M. (IST) on Tuesday, September 15, 2026
  • End of remote e-voting: Till 5:00 P.M. (IST) on Thursday, September 17, 2026
  • Cut-off date for AGM and e-voting: Friday, September 11, 2026

The communication was sent because the shareholder's email address was not registered against their demat account/folio number based on records available with the Company and/or its Registrar and Share Transfer Agent (RTA), KFin Technologies Limited.

Document Availability:

The AGM Notice and Annual Report 2025-26 can be accessed through the following channels:

  • Company website: www.neclife.com (specific pages: about-1 and about-3-9)
  • Stock exchange websites: www.bseindia.com and www.nseindia.com
  • KFin Technologies Limited e-voting portal: https://evoting.kfintech.com

Shareholder Registration Instructions:

Shareholders who wish to register their email addresses are instructed to:

  • Approach their respective Depository Participants if shares are held in electronic form
  • Write to the RTA, KFin Technologies Limited, if shares are held in physical form at:

Selenium Tower B, Plot Nos. 31-32, Gachibowli, Financial District, Nanakramguda, Hyderabad - 500032, Telangana, India

The document was signed by Sanjaymohan Singh Rawat, Company Secretary & Compliance Officer of Nectar Lifesciences Limited, on August 22, 2026.